Not Making Headlines: Japan’s Kowa Company Finds Ivermectin is Effective Against Omicron and Other COVID-19 Variants as Phase 3 Trials Continue

Kowa Company Ltd, a Japanese company specializing in trading and sales of medicines and medical equipment, announced on Monday that Ivermectin has an “antiviral effect” against Omicron and other COVID-19 variants as Phase III clinical trials continue, Reuters reported. The clinical trial found Ivermectin has “an antiviral effect” against the variant, Kowa said without providing … Continue reading Not Making Headlines: Japan’s Kowa Company Finds Ivermectin is Effective Against Omicron and Other COVID-19 Variants as Phase 3 Trials Continue